Bioprocessing Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 33.21 Bn

Forecast Year, 2035

USD 124.42 Bn

CAGR, 2026 - 2035

14.12%

Report Coverage

Global

What is the Bioprocessing Market Size?

The global bioprocessing market size is calculated at USD 33.21 billion in 2025 and is predicted to increase from USD 37.90 billion in 2026 to approximately USD 124.42 billion by 2035, expanding at a CAGR of 14.12% from 2026 to 2035. The bioprocessing market is experiencing steady expansion, driven by rapid biologics production, rising demand for advanced therapies, and continuous innovation in upstream and downstream processing technologies.

Market Highlights

• North America led the bioprocessing market with a 46.7% market share in 2035.
• Asia Pacific is expected to expand at the fastest CAGR of 12.5% between 2026 and 2035.
• By product, the upstream bioprocessing products segment captured around 58.9% of the market share in 2025.
• By product, the single-use bioprocessing products segment is growing at a strong CAGR of 10.8% from 2026 to 2035.
• By type, the bioreactors segment contributed the highest market share of 34.8% share in 2025, with single-use bioreactors segment expected to expand fastest CAGR of 11% over the projected period 2026 and 2035.
• By application, the monoclonal antibody production segment captured 38.6% of market share in 2025.
• By application, the cell & gene therapy segment is expanding at the highest CAGR of 11.4% between 2026 and 2035.
• By capacity, the large-scale bioprocessing segment led with a 56.8% share in 2025.
• By capacity, the small-scale bioprocessing segment is set to grow at the highest CAGR of 11.3% between 2026 and 2035.
• By end-user, the pharmaceutical & biotechnology companies segment held more than 43.4% of the market share in 2024.
• By end-user, the contract development & manufacturing organizations (CDMOs) segment is expected to expand at the fastest CAGR of 11.5% between 2026 and 2035

Processes in Bioprocessing Are Changing the Way Healthcare Is Delivered

Living cells, enzymes, or biologicals are used in bioprocessing to create drugs such as vaccines , biologics, cell therapies , and recombinant proteins . Bioprocessing is responsible for producing complex biological molecules in large quantities using controlled methods. As the demand for advanced biologics and cell and gene therapy increases, and the demand for precision medicine continues to increase , the bioprocessing industry is growing faster than any other area of the medical devices and pharmaceuticals industry . To maximise throughput while minimising contamination risk, companies are moving toward using continuous processing, single-use technologies, and more efficient upstream production methods.

The use of automation, digital twin technology, and AI-based process optimisation has improved batch-to-batch consistency and reduced the time required for product development, creating a positive growth environment for bioprocessing. Increased investment in expanding biologics and viral vector production capacity will continue to create a favourable climate for future growth within the industry. The increasing collaboration between biopharmaceutical companies and contract development and manufacturing organisations (CDMOs) is another factor driving the growth of bioprocessing to meet the growing need for global manufacturing capabilities.

AI-Driven Innovation for the Modern Bioprocessing Market

Artificial intelligence (AI) has become the primary catalyst for the evolution of bioprocessing technology and for changing how the biologics industry is developed, tracked, and scaled. For example, in July 2025, the Canada-UK research consortium announced its first AI-biotech coordinated experiment with a cutting-edge AI-integrated bioreactor.

Researchers and biopharmaceutical companies can now use the latest machine learning technology to optimise cell line growth conditions and predict their behaviour based on real-time data. Overall, these examples indicate a growing trend toward a digitally twin-based approach to production, predictive analytics , and autonomous upstream management. As AI products are developed and improved over time, they continue to help reduce process variability, shorten the overall development cycle, and improve batch-to-batch consistency, enabling bioprocessing to become an increasingly precise, efficient, and data-centric manufacturing environment.

What are the Major Advances Changing the Bioprocessing Market Today?

• Single-Use Systems: Increasing use of single-use bioreactor systems and filtering systems as they are more flexible, lower risk of contamination, and allow for quicker selection of different setups. A major advantage of single-use systems is their ability to produce biologics in smaller quantities than ever before, thereby minimizing the costs of building and maintaining a bioprocess facility and of cleaning.
• Continuously Operating Systems: Implementing continuous bioprocessing enables manufacturers to increase their output while offering consistent product quality and reduced footprint. In addition, continuous processing enables real-time monitoring, higher yields, and more efficient scaling of complex biologics and advanced therapies.
• Increase in the Use of Automation and AI: The impact of advanced digital technologies combined with artificial intelligence (AI) has allowed for improved process visibility, predicting process failures, and eliminating the need for manual intervention, which enhances the efficiency of the process and ultimately leading to increased reliability, optimizing the workflows, and greater consistency across both upstream and downstream stages of the process.
• Increase demand for cell and gene therapies: The current growth in demand for viral vectors and personalized medicines is driving innovation in closed-system and scalable bioprocessing systems. This trend promotes better purification techniques, improved cell management, and more robust manufacturing of next-generation therapeutics.

Market Scope

Bioprocessing Market Segment Insights

[[segment_insights]]

Bioprocessing Market Regional Insights

[[regional_insights]]

Top Players in the Bioprocessing Market and Their Offerings

• Thermo Fisher Scientific
• Sartorius AG
• Merck KGaA
• Danaher Corporation
• GE Healthcare
• Lonza Group
• Eppendorf AG
• Boehringer Ingelheim BioXcellence
• Corning Incorporated
• Repligen Corporation
• Fujifilm Diosynth Biotechnologies
• PBS Biotech
• Novasep
• Getinge AB
• Agilent Technologies

Bioprocessing MarketSegments Covered in the Report

[[segment_covered]]